Laboratorios Syva is launching Syvazul® BTV, a new multistrain vaccine against serotypes 1, 4 and 8 of the bluetongue virus.

Syvazul® BTV is the first vaccine registered by Laboratorios Syva through the EU centralised registration procedure. The marketing authorization was issued on 9th January 2019.

The vaccine is presented in the form of injectable suspension and is indicated for:

          • Active immunization of ovine livestock to prevent viraemia and reduce the clinical signs and lesions caused by serotypes 1 and/or 8 of the bluetongue virus or to reduce viraemia and the clinical signs and lesions caused by bluetongue virus serotype 4.
          • Active immunization of bovine livestock to prevent viraemia caused by serotypes 1 and/or 8 of the bluetongue virus or to reduce viraemia* caused by serotype 4 of bluetongue virus.

The most important advantage of Syvazul® BTV is its flexible use as a monovalent or combined vaccine. In this latter case, the product will contain a maximum of two of the three inactivated virus strains mentioned above, which will enable two strains to be vaccinated in just one injection.

Sheep can be vaccinated subcutaneously from 3 months of age. Cows can be vaccinated via the intramuscular route from 2 months of age. Vaccination can be performed during gestation and breastfeeding.

 

The recommendation for vaccination is as follows:

 

Sheep:

-First vaccination: administer a single 2 mL dose.

-Repeat vaccination: administer one 2 mL dose after 12 months.

 

 

Cattle:

– First vaccination: administer two 4 mL doses 3 weeks apart.

– Repeat vaccination: administer one 4 mL dose after 12 months.

 

Syvazul® BTV is available in polypropylene vials that contain 80 and 200 mL.

 


About Syva

Laboratorios Syva is a family pharmaceutical company founded in 1941 in León (Spain), dedicated exclusively to animal health through the development, production and marketing of pharmaceutical vaccines and specialties aimed at production animals.

The company is present in in Europe, Central and South America, North Africa and Asia with its own subsidiaries and an exclusive distribution network.

Journalist and press contact


 

2 September, 2021

We are evolving to move forward together in the prevention and control of swine erysipelas

Did you know that…? Did you know that according to several studies the bacteria Erysipelothrix rhusiopathiae is found asymptomatically in 30-50% of apparently healthy pigs in both white and Iberian pigs1? Did you know that swine erysipelas, is one of the 200 globally distributed zoonoses recognized by the WHO2? It is a disease transmissible from pigs to humans. The swine erysipelas is...

Read more

14 April, 2021

[Entrevista] SYVA PRIZE: Two leading figures from the CNB-CSIC for a thesis

As we explained in our press release, the directors of the thesis “Porcine epidemic diarrhoea virus: pathogenesis and protection”defended by the winner of the Syva Award – Alejandro Pascual, are two great specialists in coronaviruses, heavily involved as experts and advisors to the government in the fight against the current pandemic. Although it seems it is no longer necessary...

Read more

14 April, 2021

SYVA AWARD 2021 : the jury has chosen our winner!

It was no easy task for the Syva Award jury to determine the winner. Indeed, no less than 17 candidates submitted their theses, all of which were of excellent quality. Of course, all criteria had to be met and the highest possible score had to be achieved for each of them. After two days of deliberations, which were conducted...

Read more